Abstract
Introduction
Dendritic cells (DCs) are bone marrow-derived antigen-presenting cells (APCs) that play a fundamental role in initiating and regulating immune responses (1) . DCs are migratory cells whose functions are associated with specific differentiation stages (1) .
"Immature" DCs are found primarily at sites of antigen exposure in peripheral tissues, such as the lung and gut, where they internalize and process foreign antigen. Microbial products or inflammatory mediators stimulate DCs to differentiate or "mature" by altering the expression of chemokine receptors, and other T cell regulatory molecules, leading to the coordinated movement of DCs from peripheral sites to lymphoid tissues. Once in the lymph nodes, DCs are primed to become potent activators of T cells. Thus, the distinct ability of DCs to both 1) recognize and respond to dangerous pathogens and other inflammatory mediators in the periphery and 2) influence the activation of naïve T cells in lymph nodes, is critical for the initiation of an appropriate immune response.
The initiation of immune responses by DCs is influenced by endogenous and exogenous factors that modulate the ability of DCs to direct T cells to become anergic, memory, or effector T cells (2) .
For example, microbial products, such as mercaptoethanol) in the presence of 5% granulocyte macrophage-colony stimulating factor (GM-CSF) culture supernatant (provided by Dr. Chris Nicchitta, Duke University, Durham, NC). Cells were washed on days 2 and 4. Immature BMDC were collected on day 6 and purified further by negative selection with biotin-labeled anti-GR-1 followed by magnetic cell sorting with MACS streptavidin beads (Miltenyi Biotec, Auburn, CA). The cells were matured by culture in 24-well plates at 5 X10 5 cells/ml for 24 hours. On day 7, the nonadherent cells were collected and used as mature BMDCs. Immature and mature cells were routinely characterized for cell surface expression by flow cytometry.
Immature cells were GR-1 negative; CD80, CD86, and MHC class II low; and CD11c
positive. Mature cells were routinely GR-1 negative, MHC class II high, and CD80, CD86, and CD11c positive. The phenotype of DCs was also assessed by cytospin;
mature DCs exhibited a typical stellate shape (25).
Protein Isolation. Human SP-A was purified from the bronchoalveolar lavage fluid of patients with alveolar proteinosis via butanol extraction as previously described (15) .
SP-A was treated with polymyxin agarose to reduce endotoxin contamination and all
SP-A preparations were tested for endotoxin by the Limulus amebocyte lysate assay QCL-1000 (BioWhittaker, Walkersville, MD) and were found to have < 0.5 pg endotoxin/ µg SP-A. Recombinant rat SP-D was purified by maltose affinity chromatography from the medium supernatant of cultured Chinese hamster ovary cells expressing a fulllength rat SP-D cDNA clone as previously described (26). The SP-D preparations were tested for endotoxin and were found to have < 0.5 pg endotoxin/ µg SP-D.
Manuscript # LCMP-0018-2002 Final Accepted Version
Human serum complement component 1q (C1q) was purchased from Advanced
Research Technologies (San Diego, CA).
FACS Characterization for Maturation Markers.
Immature BMDCs were cultured in 24-well plates at 5 X 10 5 cells/ml in macrophage serum free medium (MSFM, Life
Technologies) containing 10 mM HEPES, 50 µM 2-mercaptoethanol, and 100 U/ml penicillin-streptomycin. The cells were stimulated in the presence or absence of 100 Chemotaxis. Chemotaxis assays were performed as described previously (14, 29 
SP-A regulates phenotypic changes of dendritic cells
Non-adherent day 6 immature bone marrow-derived dendritic cells (BMDCs)
were used in experiments to test the effects of surfactant protein A (SP-A) on DC differentiation, using an approach similar to other studies (32) . SP-A was incubated with day 6 immature BMDCs for 24 h in the absence of serum or GM-CSF to minimize the effects of exogenous factors on DC maturation (32, 33) . The results in Fig. 2 (Fig. 2B) . The inhibition of MHC class II (Fig. 3A) and CD86 ( Fig.   3B ) expression by SP-A was dose-dependent from 10 to 120 µg/ml of SP-A, concentrations estimated to be within physiological ranges in the lung (11). However, SP-A had no significant effect on the expression of the DC-restricted antigen CD11c
( Fig. 2A) . As expected, treatment of immature BMDCs with LPS resulted in an upregulation of both MHC class II and CD86 compared to untreated cells, which was also inhibited by SP-A ( Fig. 2A,B) . The effect of SP-A on LPS-induced maturation was similar using either a rough (LCD25) or smooth (O55:B5) serotype of LPS (data not shown). Likewise, the effect of SP-A on DC differentiation was independent of the maturation stimulus since SP-A significantly inhibited expression of MHC class II and CD86 in GM-CSF supplemented medium (data not shown).
To determine whether SP-A mediated additional changes in the phenotype of BMDCs, the expression of other DC regulatory molecules was assessed. Table I 
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The modulation of maturation marker expression by SP-A is shared by the structurally similar protein C1q
To examine whether the regulation of DC differentiation was specific to SP-A, other members of the collectin family, and the structurally similar protein C1q, were tested in experiments with BMDCs. Table II 
SP-A and C1q inhibit the allostimulatory ability of dendritic cells
The primary function of DCs to activate T cells is dependent on the expression of (Table   III) . The treatment of BMDCs with 1 µg/ml SP-D did not affect T cell proliferation (data not shown). Like the MR, SP-A is a C-type lectin with similar carbohydrate binding specificities (36) .
SP-A and C1q enhance the endocytic capacity of dendritic cells
Thus, to ensure that any SP-A remaining after the 24 h incubation was not responsible for the enhanced uptake of FITC-dextran, 25 µg/ml of SP-A was added to the untreated cells during the uptake reaction. Neither exogenously added SP-A nor C1q significantly increased the uptake of FITC-dextran (data not shown).
Treatment with SP-A or C1q affects dendritic cell chemotaxis
The ability of DCs to stimulate T cells in lymphoid tissues is dependent on the regulated expression of chemokine receptors (37) . 
